CA2446093A1 - Methods of preventing uvb-induced skin damage - Google Patents

Methods of preventing uvb-induced skin damage Download PDF

Info

Publication number
CA2446093A1
CA2446093A1 CA002446093A CA2446093A CA2446093A1 CA 2446093 A1 CA2446093 A1 CA 2446093A1 CA 002446093 A CA002446093 A CA 002446093A CA 2446093 A CA2446093 A CA 2446093A CA 2446093 A1 CA2446093 A1 CA 2446093A1
Authority
CA
Canada
Prior art keywords
tsp
angiogenesis
subject
composition
uvb
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002446093A
Other languages
English (en)
French (fr)
Inventor
Michael J. Detmar
Kiichiro Yano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2446093A1 publication Critical patent/CA2446093A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002446093A 2001-04-13 2002-04-11 Methods of preventing uvb-induced skin damage Abandoned CA2446093A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28387401P 2001-04-13 2001-04-13
US60/283,874 2001-04-13
PCT/US2002/011403 WO2002083088A1 (en) 2001-04-13 2002-04-11 Methods of preventing uvb-induced skin damage

Publications (1)

Publication Number Publication Date
CA2446093A1 true CA2446093A1 (en) 2002-10-24

Family

ID=23087934

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002446093A Abandoned CA2446093A1 (en) 2001-04-13 2002-04-11 Methods of preventing uvb-induced skin damage

Country Status (8)

Country Link
US (1) US6712617B2 (enExample)
EP (1) EP1377253A4 (enExample)
JP (1) JP2004526758A (enExample)
KR (2) KR20040021598A (enExample)
CN (1) CN100340287C (enExample)
CA (1) CA2446093A1 (enExample)
TW (1) TWI233361B (enExample)
WO (1) WO2002083088A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040266706A1 (en) * 2002-11-05 2004-12-30 Muthiah Manoharan Cross-linked oligomeric compounds and their use in gene modulation
TWI312681B (en) * 2001-02-01 2009-08-01 Novel physiologically active substance
TWI334866B (en) * 2002-05-29 2010-12-21 Mercian Corp Novel physiologically active substances
US7238370B2 (en) * 2002-06-14 2007-07-03 Rosenberg E William Method and composition to prevent and treat photoaging of skin
EP1559429A4 (en) * 2002-06-25 2009-09-09 Shiseido Co Ltd AGAIN AGING AGING
JP4328293B2 (ja) * 2002-07-31 2009-09-09 メルシャン株式会社 新規生理活性物質
US7576204B2 (en) * 2002-07-31 2009-08-18 Mercian Corporation Heterocyclic macrolide pharmaceutical agent, a method of producing the same and use of the same
US7458982B2 (en) 2002-10-04 2008-12-02 Photokinetix, Inc. Photokinetic delivery of biologically active substances using pulsed incoherent light
DE10254214A1 (de) * 2002-11-20 2004-06-09 Beiersdorf Ag Oligoribonukleotide zur Behandlung von degenerativen Hauterscheinungen durch RNA-Interferenz
EP1580278A4 (en) * 2002-11-29 2010-08-25 Mercian Corp METHOD FOR PRODUCING A MAKROLIDE COMPOUND
WO2005097187A2 (en) * 2004-04-01 2005-10-20 The General Hospital Corporation Methods of preventing uvb-induced skin damage
US20050276762A1 (en) * 2004-06-15 2005-12-15 Tapas Das Topical compositions containing 5'-adenosine-diphosphate ribose
US8795315B2 (en) * 2004-10-06 2014-08-05 Cook Medical Technologies Llc Emboli capturing device having a coil and method for capturing emboli
CA2869452C (en) 2004-10-12 2016-01-19 Tq Delta, Llc Resource sharing in a telecommunications environment
BRPI0613548A2 (pt) * 2005-05-05 2011-01-18 Genencor Int composições de cuidado pessoal e métodos para seu uso
EP2561882A3 (en) * 2005-09-16 2013-04-17 Shiseido Company, Ltd. Novel vascular endothelial growth factor expression inhibitors
EP1984522B1 (en) 2006-01-18 2010-08-11 The General Hospital Corporation Methods of increasing lymphatic function
BRPI0709871B1 (pt) 2006-04-12 2019-10-15 Tq Delta, Llc. Retransmissão de pacote e compartilhamento de memória
US20080119433A1 (en) * 2006-07-06 2008-05-22 Aaron Thomas Tabor Compositions and Methods for Genetic Modification of Cells Having Cosmetic Function to Enhance Cosmetic Appearance
EP2052723A4 (en) * 2006-08-14 2010-07-28 Eisai R&D Man Co Ltd STABLE LYOPHILIZED PREPARATION
MX2009008068A (es) * 2007-01-29 2009-11-18 Eisai R&D Man Co Ltd Compuesto macrolido en forma solida, proceso para su preparacion y composicion farmaceutica que lo contiene.
CA2698812A1 (en) 2007-09-14 2009-03-19 Nitto Denko Corporation Drug carriers
EP4219708A3 (en) 2009-07-17 2023-10-11 Aaron Thomas Tabor Compositions and methods for genetic modification of cells having cosmetic function to enhance cosmetic appearance
EP2484359B1 (en) 2009-09-30 2018-07-25 Shiseido Company, Ltd. Heparanase activity inhibitor
WO2021133858A1 (en) * 2019-12-24 2021-07-01 Juvena Therapeutics, Inc. Heparin-associated polypeptides and uses thereof
WO2021133822A1 (en) 2019-12-24 2021-07-01 Juvena Therapeutics,Inc. Regenerative polypeptides and uses thereof
EP4359425A4 (en) 2021-06-21 2025-04-09 Juvena Therapeutics, Inc. REGENERATIVE POLYPEPTIDES AND THEIR USES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025334A (en) 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
US6372234B1 (en) * 1997-05-27 2002-04-16 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
ES2301197T3 (es) * 1997-05-27 2008-06-16 Sembiosys Genetics Inc. Utilizaciones de cuerpos oleosos.
WO1999026649A1 (en) * 1997-11-25 1999-06-03 Cornell Research Foundation, Inc. Methods and compositions for inhibiting hiv infectivity and blocking chemokine activity
CA2368657A1 (en) * 1999-03-31 2000-10-05 The General Hospital Corporation Thrombospondin-2 and uses thereof
US6673843B2 (en) * 1999-06-30 2004-01-06 Emory University Curcumin and curcuminoid inhibition of angiogenesis

Also Published As

Publication number Publication date
KR20040021598A (ko) 2004-03-10
TWI233361B (en) 2005-06-01
US20030008821A1 (en) 2003-01-09
KR20080108366A (ko) 2008-12-12
WO2002083088A1 (en) 2002-10-24
EP1377253A1 (en) 2004-01-07
CN100340287C (zh) 2007-10-03
US6712617B2 (en) 2004-03-30
JP2004526758A (ja) 2004-09-02
CN1512868A (zh) 2004-07-14
EP1377253A4 (en) 2008-09-03

Similar Documents

Publication Publication Date Title
US6712617B2 (en) Methods of preventing UVB-induced skin damage
McGrath et al. Structure and function of the skin
US6773881B2 (en) Methods of modulating hair growth
ES2403517T3 (es) Aparato y método de procesamiento de datos
AU2001253012B2 (en) Methods of modulating hair growth
AU2001253012A1 (en) Methods of modulating hair growth
EP1311277A4 (en) METHODS OF FIBROSIS MODULATION
Hanakawa et al. Desmogleins 1 and 3 in the companion layer anchor mouse anagen hair to the follicle
ES2402672T3 (es) Uso del GDF-5 para el mejoramiento o el mantenimiento del aspecto dérmico
Konstantinov et al. Lipoid proteinosis
US20050276765A1 (en) Preventing skin damage
Miracco et al. Delayed skin reaction to Red Sea coral injury showing superficial granulomas and atypical CD30+ lymphocytes: report of a case
US7410756B2 (en) Methods of modulating angiogenesis
AU2002254588B2 (en) Methods of Preventing UVB-Induced Skin Damage
AU2002254588A1 (en) Methods of Preventing UVB-Induced Skin Damage
Erdle et al. 14. Wound Healing; Cutaneous Therapy; Hair

Legal Events

Date Code Title Description
FZDE Discontinued